Literature DB >> 12145817

New strategies to enhance gene therapy efficiency.

Cheng Qian, Bruno Sangro, Jesús Prieto.   

Abstract

Mesh:

Substances:

Year:  2002        PMID: 12145817     DOI: 10.1053/gast.2002.35132

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  4 in total

1.  Intratumoral versus intravenous gene therapy using a transcriptionally targeted viral vector in an orthotopic hepatocellular carcinoma rat model.

Authors:  Young Il Kim; Byeong-Cheol Ahn; John A Ronald; Regina Katzenberg; Abhinav Singh; Ramasamy Paulmurugan; Sunetra Ray; Sanjiv S Gambhir; Lawrence V Hofmann
Journal:  J Vasc Interv Radiol       Date:  2012-03-02       Impact factor: 3.464

2.  Targeting eradication of chronic myeloid leukemia using chimeric oncolytic adenovirus to drive IL-24 expression.

Authors:  Xubin Wei; Li Liu; Gang Wang; Wei Li; Ke Xu; Xupang Hu; Cheng Qian; Jimin Shao
Journal:  Int J Clin Exp Pathol       Date:  2015-04-01

3.  Combined therapy with cytokine-induced killer cells and oncolytic adenovirus expressing IL-12 induce enhanced antitumor activity in liver tumor model.

Authors:  Zhi Yang; Qianzhen Zhang; Ke Xu; Juanjuan Shan; Junjie Shen; Limei Liu; Yanmin Xu; Feng Xia; Ping Bie; Xia Zhang; Youhong Cui; Xiu-Wu Bian; Cheng Qian
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

4.  A hypoxia- and telomerase-responsive oncolytic adenovirus expressing secretable trimeric TRAIL triggers tumour-specific apoptosis and promotes viral dispersion in TRAIL-resistant glioblastoma.

Authors:  Eonju Oh; JinWoo Hong; Oh-Joon Kwon; Chae-Ok Yun
Journal:  Sci Rep       Date:  2018-01-23       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.